文献速递妇产影像腹部介入US

期待治疗管理剖宫产瘢痕妊娠的结局:系统综述与Meta分析

Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-01-01

该系统综述与Meta分析纳入17项研究共69例期待治疗的剖宫产瘢痕妊娠(CSP),按诊断时有无胚胎/胎儿心管搏动分层。有胎心组中13.0%发生无并发症流产,20.0%需医疗干预,9.9%发生早/中孕期子宫破裂,15.2%需子宫切除,76.9%进展至晚孕期,其中39.2%发生严重出血,74.8%分娩时诊断为异常侵入性胎盘,约三分之二为穿透性胎盘。无胎心组中69.1%发生无并发症流产,30.9%需手术或药物干预,13.4%发生早孕期子宫破裂,无子宫切除。

要点

  • 有胎心CSP期待治疗者严重出血、早孕期子宫破裂、子宫切除及严重异常侵入性胎盘风险高。
  • 有胎心CSP中76.9%可进展至晚孕期,但其中39.2%发生严重出血、74.8%分娩时诊断为异常侵入性胎盘。
  • 无胎心CSP期待治疗者69.1%无并发症流产,13.4%发生早孕期子宫破裂,无需子宫切除。

核心结论

  • 有胎心CSP期待治疗与包括严重出血、早孕期子宫破裂、子宫切除和严重异常侵入性胎盘在内的高母体发病率相关;尽管如此,相当比例CSP妊娠可进展至或接近足月,因此对终止妊娠是否为唯一治疗选择提出疑问。无胎心CSP期待治疗因需干预的母体并发症可能性低而可能是合理选择,但建议密切监测以避免不良母体结局。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE和ClinicalTrials.gov数据库,并手工检索相关文章和综述的参考文献列表;共纳入17项研究、69例期待治疗的CSP病例,其中52例有胚胎/胎儿心管搏动、17例无胚胎/胎儿心管搏动;采用随机效应模型对比例进行Meta分析合并数据,并按诊断时有无胚胎/胎儿心管搏动进行分层。

诊断标准与关键数值

  • 有胎心CSP组:无并发症流产13.0%(95%CI 3.8-26.7%),需医疗干预20.0%(95%CI 7.1-37.4%),早/中孕期子宫破裂9.9%(95%CI 2.9-20.4%),子宫切除15.2%(95%CI 3.6-32.8%)。
  • 有胎心CSP组:76.9%(95%CI 65.4-86.5%)进展至晚孕期,其中严重出血39.2%(95%CI 15.4-66.2%),分娩时手术或病理诊断异常侵入性胎盘74.8%(95%CI 52.0-92.1%),其中穿透性胎盘69.7%(95%CI 42.8-90.1%)。
  • 无胎心CSP组:无并发症流产69.1%(95%CI 47.4-87.1%),流产期间或流产后立即需手术或药物干预30.9%(95%CI 12.9-52.6%),早孕期子宫破裂13.4%(95%CI 2.7-30.3%),无需子宫切除。

临床应用与阅片要点

  • 作者认为,无胎心CSP期待治疗因需干预的母体并发症可能性低而可能是合理选择,但建议密切监测以避免不良母体结局;对有胎心CSP,作者对终止妊娠是否为唯一治疗选择提出疑问。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To explore the outcome in women managed expectantly following the diagnosis of Cesarean scar pregnancy (CSP).

METHODS: An electronic search of MEDLINE, EMBASE and ClinicalTrials.gov databases was performed utilizing combinations of relevant medical subject headings for 'Cesarean scar pregnancy' and 'outcome'. Reference lists of relevant articles and reviews were hand-searched for additional reports. Observed outcomes included: severe first-trimester vaginal bleeding; clinical symptoms (abdominal pain, vaginal bleeding) requiring treatment; uncomplicated miscarriage; complicated miscarriage requiring intervention; first- or second-trimester uterine rupture or hysterectomy; third-trimester bleeding, uterine rupture or hysterectomy; maternal death; incidence of abnormally invasive placenta (AIP); prevalence of placenta percreta; ultrasound signs suggestive of AIP; and live birth. Meta-analyses of proportions using a random-effects model were used to combine data. Cases were stratified based on the presence or absence of embryonic/fetal heart activity at the time of diagnosis.

RESULTS: A total of 17 studies (69 cases of CSP managed expectantly, 52 with and 17 without embryonic/fetal heart beat) were included. In women with CSP and embryonic/fetal heart activity, 13.0% (95% CI, 3.8-26.7%) experienced an uncomplicated miscarriage, while 20.0% (95% CI, 7.1-37.4%) required medical intervention. Uterine rupture during the first or second trimester of pregnancy occurred in 9.9% (95% CI, 2.9-20.4%) of cases, while hysterectomy was required in 15.2% (95% CI, 3.6-32.8%) of all cases. Forty (76.9% (95% CI, 65.4-86.5%)) women progressed to the third trimester of pregnancy, of whom 39.2% (95% CI, 15.4-66.2%) experienced severe bleeding. Finally, 74.8% (95% CI, 52.0-92.1%) had a surgical or pathological diagnosis of AIP at delivery and around two-thirds (69.7% (95% CI, 42.8-90.1%)) of them had placenta percreta. In women with CSP but no embryonic/fetal cardiac activity, an uncomplicated miscarriage occurred in 69.1% (95% CI, 47.4-87.1%) of cases, while surgical or medical intervention during or immediately after miscarriage was required in 30.9% (95% CI, 12.9-52.6%). Uterine rupture during the first trimester of pregnancy occurred in 13.4% (95% CI, 2.7-30.3%) of cases, but hysterectomy was not required in any case.

CONCLUSIONS: CSP with positive embryonic/fetal heart activity managed expectantly is associated with a high burden of maternal morbidity including severe hemorrhage, early uterine rupture, hysterectomy and severe AIP. Despite this, a significant proportion of pregnancies complicated by CSP may progress to, or close to, term, thus questioning whether termination of pregnancy should be the only therapeutic option offered to these women. Expectant management of CSP with no cardiac activity may be a reasonable option in view of the low likelihood of maternal complications requiring intervention, although close surveillance is advisable to avoid adverse maternal outcome. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Calì G, Timor-Tritsch IE, Palacios-Jaraquemada J, et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018. PMID: 28661021. doi:10.1002/uog.17568

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。